CXCL1 and breast cancer: In addition, binding of TAM-derived CXCL1 to SOX4 promoter enhances its promoter activity via the NF-κB pathway, and silencing CXCL1 in TAMs showed a significant reduction in breast cancer progression and metastasis [177].